Fig. 4. Changes in irritable bowel syndrome (IBS)–quality of life (QoL) at week 4 compared to the baseline. There was no significant difference in total IBS-QoL score at week 4 between the 2 groups (P = 0.897).

J Neurogastroenterol Motil 2022;28:265~275 https://doi.org/10.5056/jnm20236

© J Neurogastroenterol Motil